Roche Holding AG (FRA:RHO)

Market Cap	283.45B
Revenue (ttm)	67.98B
Net Income (ttm)	10.10B
Shares Out	n/a
EPS (ttm)	12.57
PE Ratio	28.08
Forward PE	16.27
Dividend	9.70 (2.84%)
Ex-Dividend Date	Mar 27, 2025

Volume	23
Average Volume	72
Open	340.20
Previous Close	345.80
Day's Range	340.20 - 342.20
52-Week Range	270.20 - 352.60
Beta	n/a
RSI	61.72
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RHO

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF